Connect your AI

Nathan's Famous NATH Product Licensing — Interest Expense Nonoperating

Other segment segments

Branded Product Program

$0—

Restaurant Operations

$0—

Similar metrics at other companies

LGNDDevelopment and Licensing of Biopharmaceutical Assets — Interest Expense, Nonoperating

$1.75M+101%

ADEAIntellectual Property Licensing — Interest Expense Debt

$8.55M-19.7%

AMP

AMPHPharmaceutical Products — Interest Expense Nonoperating

$6.55M+4.2%

ONDSInterest Expense, Nonoperating

$338K-91.3%

DCInterest Expense, Nonoperating

$34.37K—

CVCOFinancial services — Interest Expense, Nonoperating

$0—

Other financials

Income statement

Revenue$35.1M+13.9%

Gross profit$12.5M+4.7%

Operating income$4.7M-26.5%

Net income$2.8M-33.7%

EPS (diluted)$0.68-34.0%

Balance sheet

Cash & equivalents$24.4M-12.2%

Total debt$52.1M-6.9%

Total equity-$14.2M+13.9%

Total assets$53.7M+0.3%

Cash flow

Operating cash flow$2.5M-62.6%

CapEx$38.0K-29.6%

Free cash flow$2.5M-62.8%

Valuation

Market cap$416.07M-7.2%

Enterprise value$443.76M-6.8%

P/E20.8×+2.1×

P/S2.6×-0.5×

Profitability

Gross margin34.3%-5.2pp

Operating margin18.6%-6.1pp

Net margin12.4%-3.9pp

FCF margin11%-5.9pp

Returns & leverage

Return on equity21.3%—

Debt / equity-3.7×—

Current ratio2.5×-0.2×

Where this comes from

Reported directly by Nathan's Famous in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Nathan's Famous’s 10-K, filed June 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nathan's Famous's product licensing — interest expense nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Nathan's Famous's product licensing — interest expense nonoperating?: Nathan's Famous (NATH) reported product licensing — interest expense nonoperating of $0 in Q1 2026.
What does product licensing — interest expense nonoperating mean?: Represents the interest costs incurred by the product licensing segment that are not directly related to core operating activities. This metric helps investors isolate the financing burden specifically associated with the licensing business unit. It is a key indicator of how much debt-related overhead is allocated to this segment's financial performance.